The FDA Modernization Act 2.0 allows bioengineered models in drug testing, including benchtop testing and computational models. These alternatives to animal testing may particularly advance drug discovery in reproductive and pregnancy research.
Nature Reviews Bioengineering.
2024;2(12):984-986. doi: 10.1038/s44222-024-00252-8
Library Collection(s)